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suggesting the importance of diet in OA pathology. Future work is
needed to compare the independent effects of leptin and obesity with
or without inﬂammation on the underlying molecular mediators of
cartilage degeneration.
Figure 1. Knee OA scores in leptin receptor mutant Zucker fatty rats (A) and F344BN
rats undergoing chronic systemic leptin treatment (B). Obesity in the absence of leptin
signaling and increased systemic leptin in the absence of obesity were both sufﬁcient
to induce site-speciﬁc increases in spontaneous knee OA (*p<0.05).86
SYNOVIAL WNT AND WISP1 EXPRESSION INDUCES CARTILAGE
DAMAGE BY SKEWING OF TGF-BETA SIGNALING VIA THE
CANONICAL WNT SIGNALING PATHWAY
M. van den Bosch, A. Blom, P. van Lent, H. van Beuningen, F. van de
Loo, E. Blaney Davidson, P. van der Kraan, W. van den Berg. Radboud
Univ. Nijmegen Med. Ctr., NCMLS, Nijmegen, Netherlands
Purpose: Many osteoarthritis (OA) patients show signiﬁcant synovial
involvement. Recently, we found strong upregulation of canonical Wnts
2b and 16 and Wnt-1 induced signaling protein 1 (WISP1), a down-
stream protein, in the synovium in two murine OA models. Wnt
signaling has been implicated in OA through activation of the b-catenin
pathway. In addition, TGF-b signaling is critical in cartilage mainte-
nance. TGF-b signals via both ALK5 and ALK1 and downstreamvia Smad
2/3 and Smad 1/5/8 respectively. In the present study we investigated
the potential of canonical Wnts to skew TGF-b signaling from the
protective Smad 2/3 pathway towards the Smad 1/5/8 pathway, which
can induce chondrocyte hypertrophy.
Methods: Pathway analysis of microarray data from the synovium of
a collagenase-induced OA (CIOA) mouse model was done using DAVID
software. In vivo synovial overexpression of genes from the canonical
Wnt signaling pathway was achieved by intra-articular injection of
adenoviral vectors. Gene expression was analyzed by qPCR after over-
expression ofWnt genes in human chondrocytes. Detection of Smad 2/3
and Smad 1/5/8 phosphorylation was done by Western blot analysis.
Functional TGF-b signaling via ALK5 was measured using the luciferase
reporter construct CAGA-Luc.
Results: Pathway analysis using DAVID, showed that both the Wnt and
TGF-b signaling pathway were enriched in the synovium of mice with
CIOA. Because of their relatively small size, Wnts and WISP1 proteins
can migrate into the cartilage and possibly alter chondrocyte pheno-
type. To determine if synovial overexpression of canonicalWnts leads to
Wnt signaling in the cartilage, we injected adenoviral vectors forWnt8a
and Wnt16 into murine knee joints. These vectors speciﬁcally target
synovial cells, because due to their size they cannot enter the cartilage.
Synovial overexpression of Wnt8a and Wnt16 led to b-catenin accu-
mulation in chondrocytes, a tell-tale sign of canonical Wnt signaling. In
vitro overexpression of canonical Wnts and WISP1 in human chon-
drocytes led to signiﬁcantly increased collagen type X and signiﬁcantly
decreased type II collagen expression, suggesting a loss of chondrocyte
phenotype. Moreover, pre-incubation with Wnt3a and/or WISP1
resulted in decreased TGF-b-induced phosphorylation of Smad 2/3,
whereas phosphorylation of Smad 1/5/8 was increased in both murine
and human chondrocytes. This implies a shift towards dominant TGF-
b signaling via the hypertrophy-inducing ALK1 pathway. On a func-
tional level, pre-incubation with Wnt3a and/or WISP1 led to decreased
CAGA-Luc reporter construct activity, conﬁrming decreased ALK5
signaling. Moreover, the expression of the anti-hypertrophic factor Sox9
was decreased after pre-incubation with Wnt3a and WISP1. In order to
investigate whether Wnt3a skews the TGF-b signaling via the canonicalsignaling pathway, we pre-incubated chondrocytes with Wnt3a and/or
WISP1 in the presence of DKK-1, a selective inhibitor of the canonical
Wnt signaling pathway. Compared to the groups without DKK-1, we
found increased Smad 2/3 phosphorylation and decreased phosphory-
lation of Smad 1/5/8 after Wnt3a stimulation.
Conclusions: Wnts produced in the synovium may play an important
role in OA pathology by changing the chondrocyte phenotype, probably
through modulation of the important TGF-b signaling pathway via the
canonical Wnt signaling pathway. This points towards Wnt/WISP1
expression in the synovium as an interesting target for OA therapy.87
MECHANICAL LOAD-INDUCED BONE REMODELING REQUIRES FSTL3
EXPRESSION
A. Blazek, P. Perera, D. Knapik, L.-C. Wu, A. Litsky, Z. Sun, D.-G. Kim,
B. Lebelebicioglu, S. Agarwal. The Ohio State Univ., Columbus, OH, USA
Purpose: Physical activity is shown to strengthen bone, however, its
molecular mechanisms remain unclear. Here, we identiﬁed a molecule,
FSTL3 (NM_005860), that may drive mechanical load-dependent bone
remodeling.
Methods: IACUC at the Ohio State University approved all protocols.
Female Sprague Dawley rats (12-14 wks, n¼10), wild-type (WT, 10-12
wks, n¼10/group) or homozygous FSTL3-/- C57Bl/6 mice (10-12 wks,
n¼10) were subjected to exercise by treadmill walking at 12 M/min
(rats) or 8 M/min (mice) for 45 min/day. Following 0, 2, 5 or 15 days of
exercise, animals were sacriﬁced and gene expression analyzed by
quantitative real time polymerase chain reaction (qrtPCR), Western
blots, or immunohistochemistry of the trabecular bone/bone marrow at
the distal ends of femurs. Bone mineral apposition rates in wild type or
FSTL3-null mice was assessed by administration of Calcein and Alizarin
complexones on day 3 and 12, during the total exercise period of 15
days. Statistical analysis was performed by one-way ANOVA with
Tukey's post hoc or T-test.
Results: Trabecular bones/bone marrow from exercised healthy mice
for 2 or 5 days were subjected to the gene expression analysis of Fstl3,
Follistatin (Fst), Inhibin-Alpha (Inha), Inhibin-Beta-A (Inhba), and
-Beta-B (Inhbb) that are known to regulate ligands in TGF-b super-
family. The qrtPCR revealed that exercise dramatically stimulated Fstl3
mRNA expression in the trabecular bone and bone marrow cells,
reaching 6 fold increase on day 2 and then declining to basal levels by
day 5. However, there was no signiﬁcant change in the expression of
Inha, Inhba, and Inhbb. The expression of FSTL3 in osteoblasts at the
protein level assessed by immunoﬂuorescence in the sagittal sections of
rat femurs exhibited minimal presence of FSTL3 in the control non-
exercised trabecular bone or cells lining trabecular bones. However,
a robust increase in FSTL3 expressionwas observed in the femurs of rats
subjected to exercise at day 2 and 5, predominantly within and adjacent
to trabecular bones. Osteocalcin used as a positive marker for osteo-
blasts in adjacent sections of the same bones, conﬁrmed the osteo-
blastic phenotype of FSTL3 positive cells lining the bone. Female Fstl3+/+,
Fstl3-/-, and Fstl3+/- mice (12 wks old) subjected to exercise for 15
consecutive days, exhibited signiﬁcantly narrow distance between the
Calcein and Alizarin incorporation and limited bone deposition in all
three groups of non-exercised control mice. Fstl3+/+ and Fstl3+/- mice
when subjected to exercise demonstrated a signiﬁcant increase in bone
deposition on the endosteal surface of the posterior side of the femur
together with increase in the total MAR (Fig 1). Strikingly, such exercise-
induced bone formation and hence increase in MARwas not observed in
Fstl3-/-mice. The representative stress-strain curves of the cortical bone
of the WT and Fstl3 -/- femurs under three point bending test revealed
that strain at ultimate strength of femurs from WT mice was approxi-
mately 25% greater than that of Fstl3 -/- mice. Furthermore, the yield
strain and yield energy were signiﬁcantly upregulated by exercise inWT,
but not in Fstl3-/- mice. Another evidence of FSTL3 in bone formation
was more rounded shape and uniform deposition of calcein and alizarin
complexone at the periosteal as well as endosteal surfaces of the femur
in the Fstl3-/- mice.
Conclusions: The identiﬁcation of FSTL3 as a mechanoresponsive
protein may provide a new paradigm for investigating exercise-driven
bone formation and a marker to monitor the effects of exercise on bone
in health and in a wide spectrum of diseases. We further anticipate that
FSTL3 may serve as a target to develop therapeutic drugs for treating
bone diseases.
Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62 S55Figure 1. Fstl3 gene deletion results in the loss of load dependent of bone growth
(a) Sagittal section of rat femur showing the position of cross sections. (a-b) Double
ﬂuorochrome-labeled sections of femurs at the distal diaphyseal end at planes I and II
showing minimal bone Deposition in non-loaded control and loaded Fstl3+/+, Fstl3-/-,
and Fstl3+/- mice. Note the bone deposition (i) at the medial (arrow) endosteal surface
in Fstl3+/+ femur as compared to minimal bone formation at all sides of the Fstl3-/-
femur, and (ii) regain of mechanosensitivity in heterozygous mice.
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SCLEROSTIN REGULATION OF WISP1 AND MMPS IN CHONDROCYTES
IS DEPENDENT ON THE LRP5/6 BINDING DOMAIN BUT NOT
SECRETION FROM THE CELL
B.Y. Chan y, A. Ashton z, M.M. Smith y, C.B. Little y. yRaymond Purves Bone
and Joint Res. Lab, Kolling Inst. of Med. Res., St Leonards, Australia;
z Perinatal Med., Kolling Inst. of Med. Res., St Leonards, Australia
Purpose: Sclerostin (SOST) is a secreted protein that inhibits Wnt
signaling by binding the LRP5/6 cell-surface Wnt co-receptor. SOST has
also been reported to bind intra-cellularly and target BMPs for pro-
teosomal degradation in cells in which it is co-expressed. While
previously considered an osteocyte-speciﬁc protein, it has recently been
demonstrated that chondrocytes in non-calciﬁed articular cartilage
express SOST mRNA. Chondrocyte SOST expression is upregulated in
osteoarthritis and by inﬂammatory cytokines such as intereukin-1
(IL-1). Exogenous soluble SOST protects cartilage from IL-1-mediated
proteoglycan loss and inhibits metalloproteinase expression and
activity in vitro, but it is unclear if SOST expressed by chondrocytes
functions in the same manner. The present study aimed to investigate
the function of chondrocyte SOST, and explore the molecular mecha-
nism whereby it may function in this cell type and have chon-
droprotective effects.
Methods: Expression constructs for full length human SOST (WT), non-
secretable SOST (M1), secretable SOST with inactive LRP5/6 binding
domain (M2), and non-secretable SOST with inactive LRP5/6 binding
domain (M3) were generated using a PCR approach. In M2 and M3 the
LRP5/6 binding domain was replaced by the artemin sequence from the
same cysteine-knot familywhich does not bind LRP5/6. SW1353 human
chondrosarcoma cells were stably transfected with the different
constructs or the empty vector. SOST expression was determined by
Western blotting of cell lysates and ELISA quantitation of culture media.
Cells were cultured  IL-1 for 24 hours and cell viability (trypan blue
exclusion), cell metabolism (MTT assay), MMP1, MMP3 and MMP13
gene expression (qRT-PCR), MMP13 protein secretion (Western blot)
and MMP13 activity (ﬂuorogenic assay) were measured.
Results: Transfected cell lines synthesized SOST, with similar levels of
intracellular protein detected in all cells but secreted protein in the
media only in WT and M2 cells as expected. There was no effect of any
of the SOST expression constructs on cell viability or metabolism
compared with the vector control. M1 and M2 constructs decreased
basal (un-stimulated) MMP13 expression. IL-1 stimulated Wnt-b-cat-
enin activity as measured by signiﬁcantly increased WISP1 expression
(p < 0.05). WT and M1 SOST, signiﬁcantly (p<0.05) suppressed IL-1
induced WISP1, MMP1, MMP3 and MMP13 mRNA expression.However only WT SOST decreased MMP13 protein secretion and
activity. In contrast, M2 and M3 constructs had no effect on WISP1 or
MMP gene expression, nor MMP13 activity in the presence or absence
of IL-1.
Conclusion: Our data demonstrate for the ﬁrst time that chondrocytes
can secrete soluble SOST. Furthermorewe show that the LRP5/6 binding
domain is critical for SOSTs inhibition of IL-1 induced Wnt-b-catenin
activation and MMP expression and activity in chondrocytes. Surpris-
ingly however, secretion from the cell was not necessary for SOST to
inhibit IL-1-stimulated WISP1 expression, or for SOSTs anti-MMP
activity. This suggests a hitherto unrecognized intra-cellular role for the
LRP5/6 binding domain of SOST, potentially through cross-talk between
BMP and Wnt pathways. Improved understanding of the regulation of
these molecular pathways in chondrocytes, may lead to novel thera-
peutic approaches in diseases such as osteoarthritis.89
THE SCLEROSTIN AND MEPE AXIS IN THE DEVELOPMENT OF
OSTEOARTHRITIS
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Purpose: Sclerostin (SCL) is a natural inhibitor of Wnt signaling with
emerging compelling links with the subchondral bone (SB) changes
observed in osteoarthritis (OA). Moreover, it has recently been estab-
lished that SCL regulates bone and cartilage mineralization through the
recognised mineralization inhibitor matrix extracellular phosphogly-
coprotein (MEPE). To establish the expression and function of both SCL
and MEPE in OA, we determined the spatial relationship between their
expression and hallmarks of OA in a spontaneous model of OA, the Str/
ort mouse. Furthermore, as the re-initiation of developmental processes
in OA is well established, we sought to examine the role of SCL in
endochondral ossiﬁcation.
Methods: Knee joints from male Str/ort mice, were analysed at 8, 18
and 40+ weeks of age (before, early and late OA). Age-matched ‘OA
protected’ CBA male mice knees were also analysed. SB-thickness and
epiphyseal mass/architecture parameters were measured by microCT
analysis. Multiple sections from regular intervals across joints were
stained with Toluidine blue and scored for OA hallmarks. SCL and
MEPE expressions were then determined by immunohistochemistry
(IHC). We have previously established the role of MEPE in endochon-
dral bone growth however the role of SCL has yet to be examined. Here
embryonic and postnatal growth plates were analysed by IHC for SCL
expression to establish its temporal and spatial expression in endo-
chondral bone growth. The chondrogenic cell line ATDC5, a model of
endochondral ossiﬁcation, was cultured in mineralizing conditions for
up to 34-days and protein lysates examined for SCL expression by
western blotting.
Results: Our results revealed that SCL expression is enhanced at the
osteochondral interface at unaffected regions of the joint. Similarly,
MEPE expression is enhanced in the articular cartilage (AC) of the
lateral aspect of the Str/ort mouse joint, where SB thickening is not
observed. In OA joints, marked suppression of SCL expression at the
osteochondral interface in Str/ort mice at advanced stages of OA; in
regions of the OA joint where AC integrity is compromised and SB
thickening is observed, as shown by microCT scanning. MEPE expres-
sion is lost in the diseased aspect of the joint in both the AC and the
underlying osteocytes of the SB. Moreover, strong SCL and MEPE
expression is found close to ossiﬁed ligament insertions, menisci, and
in emerging osteophytes, which are increased with disease severity.
Osteophytes form through endochondral ossiﬁcation and as such, we
established the localisation of SCL in endochondral bone growth.
Interestingly, whilst we observe an embryonic expression of MEPE by
both proliferating, and more relevantly mineralizing hypertrophic
chondrocytes, this is lost in postnatal chondrocytes. Our results also
show increased SCL expression in ATDC5 cells throughout the 34-day
differentiation period, suggesting a role for SCL in the endochondral
processes observed in osteophyte formation.
Conclusions: Our data suggest that SCL and MEPE are pivotal in
restricting pathological ossiﬁcation in OA. Further investigation into the
precise mechanisms by which they function in OAwill identify whether
their targeted delivery can protect against OA bone pathology and will
therefore provide a basis for research towards clinical beneﬁt.
